Compounds > pramipexole
Page last updated: 2024-09-03

pramipexole and paromomycin

pramipexole has been researched along with paromomycin in 2 studies

Compound Research Comparison

Studies
(pramipexole)		Trials
(pramipexole)		Recent Studies (post-2010)
(pramipexole)		Studies
(paromomycin)		Trials
(paromomycin)		Recent Studies (post-2010) (paromomycin)
1,1032195171,42290292

Protein Interaction Comparison

ProteinTaxonomypramipexole (IC50)paromomycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.0355
30S ribosomal protein S7Escherichia coli K-120.0355
50S ribosomal protein L15Escherichia coli K-120.0355
50S ribosomal protein L10Escherichia coli K-120.0355
50S ribosomal protein L11Escherichia coli K-120.0355
50S ribosomal protein L7/L12Escherichia coli K-120.0355
50S ribosomal protein L19Escherichia coli K-120.0355
50S ribosomal protein L1Escherichia coli K-120.0355
50S ribosomal protein L20Escherichia coli K-120.0355
50S ribosomal protein L27Escherichia coli K-120.0355
50S ribosomal protein L28Escherichia coli K-120.0355
50S ribosomal protein L29Escherichia coli K-120.0355
50S ribosomal protein L31Escherichia coli K-120.0355
50S ribosomal protein L31 type BEscherichia coli K-120.0355
50S ribosomal protein L32Escherichia coli K-120.0355
50S ribosomal protein L33Escherichia coli K-120.0355
50S ribosomal protein L34Escherichia coli K-120.0355
50S ribosomal protein L35Escherichia coli K-120.0355
50S ribosomal protein L36Escherichia coli K-120.0355
30S ribosomal protein S10Escherichia coli K-120.0355
30S ribosomal protein S11Escherichia coli K-120.0355
30S ribosomal protein S12Escherichia coli K-120.0355
30S ribosomal protein S13Escherichia coli K-120.0355
30S ribosomal protein S16Escherichia coli K-120.0355
30S ribosomal protein S18Escherichia coli K-120.0355
30S ribosomal protein S19Escherichia coli K-120.0355
30S ribosomal protein S20Escherichia coli K-120.0355
30S ribosomal protein S2Escherichia coli K-120.0355
30S ribosomal protein S3Escherichia coli K-120.0355
30S ribosomal protein S4Escherichia coli K-120.0355
30S ribosomal protein S5Escherichia coli K-120.0355
30S ribosomal protein S8Escherichia coli K-120.0355
30S ribosomal protein S9Escherichia coli K-120.0355
50S ribosomal protein L13Escherichia coli K-120.0355
50S ribosomal protein L14Escherichia coli K-120.0355
50S ribosomal protein L16Escherichia coli K-120.0355
50S ribosomal protein L23Escherichia coli K-120.0355
30S ribosomal protein S15Escherichia coli K-120.0355
50S ribosomal protein L17Escherichia coli K-120.0355
50S ribosomal protein L21Escherichia coli K-120.0355
50S ribosomal protein L30Escherichia coli K-120.0355
50S ribosomal protein L6Escherichia coli K-120.0355
30S ribosomal protein S14Escherichia coli K-120.0355
30S ribosomal protein S17Escherichia coli K-120.0355
30S ribosomal protein S1Escherichia coli K-120.0355
50S ribosomal protein L18Escherichia coli K-120.0355
50S ribosomal protein L2Escherichia coli K-120.0355
50S ribosomal protein L3Escherichia coli K-120.0355
50S ribosomal protein L24Escherichia coli K-120.0355
50S ribosomal protein L4Escherichia coli K-120.0355
50S ribosomal protein L22Escherichia coli K-120.0355
50S ribosomal protein L5Escherichia coli K-120.0355
30S ribosomal protein S21Escherichia coli K-120.0355
50S ribosomal protein L25Escherichia coli K-120.0355
50S ribosomal protein L36 2Escherichia coli K-120.0355

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bernauer, E; Finsterer, J1

Reviews

1 review(s) available for pramipexole and paromomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for pramipexole and paromomycin

ArticleYear
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.
    Metabolic brain disease, 2005, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders

2005